Home/Filings/4/0001842952-21-000009
4//SEC Filing

Minai-Azary Jennifer Lynn 4

Accession 0001842952-21-000009

CIK 0001842952other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 4:31 PM ET

Size

5.3 KB

Accession

0001842952-21-000009

Insider Transaction Report

Form 4
Period: 2021-11-01
Minai-Azary Jennifer Lynn
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-11-01+52,75352,753 total
    Exercise: $5.59Exp: 2031-11-01Common Stock (52,753 underlying)
Footnotes (1)
  • [F1]The stock option vests each month (1/36 each month) from the date of the grant, November 1, 2021

Issuer

Context Therapeutics Inc.

CIK 0001842952

Entity typeother

Related Parties

1
  • filerCIK 0001844398

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:31 PM ET
Size
5.3 KB